Morgan Stanley’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$229M Buy
1,819,745
+301,508
+20% +$37.9M 0.01% 817
2025
Q1
$168M Sell
1,518,237
-55,060
-3% -$6.09M 0.01% 940
2024
Q4
$215M Buy
1,573,297
+223,916
+17% +$30.6M 0.02% 798
2024
Q3
$155M Sell
1,349,381
-195,488
-13% -$22.5M 0.01% 960
2024
Q2
$213M Sell
1,544,869
-520,767
-25% -$71.7M 0.02% 777
2024
Q1
$285M Sell
2,065,636
-2,586,952
-56% -$357M 0.02% 647
2023
Q4
$613M Buy
4,652,588
+2,728,509
+142% +$360M 0.03% 588
2023
Q3
$216M Buy
1,924,079
+56,054
+3% +$6.31M 0.02% 658
2023
Q2
$176M Buy
1,868,025
+213,132
+13% +$20.1M 0.02% 770
2023
Q1
$168M Sell
1,654,893
-393,192
-19% -$39.8M 0.02% 773
2022
Q4
$245M Buy
2,048,085
+1,511,307
+282% +$181M 0.03% 606
2022
Q3
$57M Buy
536,778
+49,503
+10% +$5.26M 0.01% 1228
2022
Q2
$47.5M Buy
487,275
+310,448
+176% +$30.3M 0.01% 1407
2022
Q1
$16.6M Buy
176,827
+37,462
+27% +$3.51M ﹤0.01% 2328
2021
Q4
$11.9M Sell
139,365
-5,526
-4% -$471K ﹤0.01% 2756
2021
Q3
$13.9M Sell
144,891
-204,709
-59% -$19.6M ﹤0.01% 2515
2021
Q2
$34M Buy
349,600
+239,383
+217% +$23.3M ﹤0.01% 1619
2021
Q1
$10.7M Sell
110,217
-14,856
-12% -$1.44M ﹤0.01% 2573
2020
Q4
$12M Sell
125,073
-158,109
-56% -$15.2M ﹤0.01% 2318
2020
Q3
$27.2M Buy
283,182
+137,503
+94% +$13.2M 0.01% 1257
2020
Q2
$17.8M Buy
145,679
+64,248
+79% +$7.84M ﹤0.01% 1503
2020
Q1
$7.05M Sell
81,431
-78,068
-49% -$6.76M ﹤0.01% 2117
2019
Q4
$17.1M Buy
159,499
+76,616
+92% +$8.24M ﹤0.01% 1802
2019
Q3
$7.47M Buy
82,883
+24,210
+41% +$2.18M ﹤0.01% 2433
2019
Q2
$4.95M Sell
58,673
-30,376
-34% -$2.56M ﹤0.01% 2926
2019
Q1
$7.85M Sell
89,049
-67,329
-43% -$5.93M ﹤0.01% 2278
2018
Q4
$11.2M Sell
156,378
-57,390
-27% -$4.1M ﹤0.01% 2014
2018
Q3
$26.3M Buy
213,768
+117,168
+121% +$14.4M 0.01% 1441
2018
Q2
$9.49M Sell
96,600
-88,201
-48% -$8.66M ﹤0.01% 2435
2018
Q1
$15.3M Buy
184,801
+133,621
+261% +$11.1M ﹤0.01% 1927
2017
Q4
$3.97M Buy
51,180
+14,805
+41% +$1.15M ﹤0.01% 3341
2017
Q3
$2.23M Sell
36,375
-16,522
-31% -$1.01M ﹤0.01% 3771
2017
Q2
$2.44M Buy
52,897
+22,094
+72% +$1.02M ﹤0.01% 3627
2017
Q1
$1.34M Sell
30,803
-16,570
-35% -$718K ﹤0.01% 4165
2016
Q4
$1.83M Buy
47,373
+6,605
+16% +$255K ﹤0.01% 4005
2016
Q3
$2.07M Sell
40,768
-23,582
-37% -$1.19M ﹤0.01% 3482
2016
Q2
$2.92M Buy
64,350
+26,900
+72% +$1.22M ﹤0.01% 3105
2016
Q1
$1.48M Sell
37,450
-28,243
-43% -$1.12M ﹤0.01% 3595
2015
Q4
$3.72M Buy
65,693
+18,767
+40% +$1.06M ﹤0.01% 2951
2015
Q3
$1.87M Buy
46,926
+16,076
+52% +$640K ﹤0.01% 3578
2015
Q2
$1.47M Sell
30,850
-73,786
-71% -$3.52M ﹤0.01% 3901
2015
Q1
$4.16M Buy
104,636
+6,095
+6% +$242K ﹤0.01% 2927
2014
Q4
$2.2M Buy
98,541
+48,368
+96% +$1.08M ﹤0.01% 3489
2014
Q3
$787K Buy
50,173
+15,385
+44% +$241K ﹤0.01% 4248
2014
Q2
$516K Buy
34,788
+13,668
+65% +$203K ﹤0.01% 4548
2014
Q1
$340K Sell
21,120
-28,878
-58% -$465K ﹤0.01% 4815
2013
Q4
$467K Buy
49,998
+3,987
+9% +$37.2K ﹤0.01% 4497
2013
Q3
$520K Sell
46,011
-23,657
-34% -$267K ﹤0.01% 4300
2013
Q2
$932K Buy
+69,668
New +$932K ﹤0.01% 3778